Bausch Health Companies Inc (BHC) is a publicly traded Healthcare sector company. As of October 7, 2026, BHC trades at $6.16 with a market cap of $2.20B and a P/E ratio of 14.42. BHC moved +1.41% today. Year to date, BHC is -16.50%; over the trailing twelve months it is -6.96%. Its 52-week range spans $4.25 to $8.69. Analyst consensus is neutral with an average price target of $9.00. Rallies surfaces BHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover BHC: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $9.00.
| Metric | Value |
|---|---|
| Price | $6.16 |
| Market Cap | $2.20B |
| P/E Ratio | 14.42 |
| EPS | $0.42 |
| Dividend Yield | 1.00% |
| 52-Week High | $8.69 |
| 52-Week Low | $4.25 |
| Volume | 213.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $10.27B |
| Net Income | $120.00M |
| Gross Margin | 0.00% |
1 analysts cover BHC: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $9.00.